The Neostigmine Methylsulfate Injection Market is estimated to be valued at Us$ 156.75 Mn in 2023 and is expected to exhibit a CAGR Of 4.5% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Neostigmine methylsulfate injection is an acetylcholinesterase inhibitor used to treat myasthenia gravis and to reverse the ... Read more
